Literature DB >> 11245147

Montelukast sodium in cystic fibrosis.

A H Morice, J A Kastelik, I Aziz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11245147      PMCID： PMC1758768          DOI： 10.1136/thorax.56.3.244a

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

Review 1.  Asthma in cystic fibrosis.

Authors:  Ian M Balfour-Lynn
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 2.  "CF asthma": what is it and what do we do about it?

Authors:  I M Balfour-Lynn; J S Elborn
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

3.  Montelukast use-a 19-year nationwide drug utilisation study.

Authors:  Daniel Pilsgaard Henriksen; Jesper Rømhild Davidsen; Christian B Laursen; Anders Christiansen; Per Damkier; Jesper Hallas; Anton Pottegård
Journal:  Eur J Clin Pharmacol       Date:  2017-06-22       Impact factor: 2.953

Review 4.  Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Authors:  Adam Jaffe; Ian M Balfour-Lynn
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Use of modulators of airways inflammation in patients with CF.

Authors:  Clement L Ren
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.